Study genes and blood markers in bile duct and gallbladder cancers
Part of Cancer, Digestive system clinical trials.
This study looks at genetic and molecular patterns in people with bile duct or gallbladder cancers, and compares them with people without cancer (or with chronic liver disease). It may help researchers understand why these cancers happen and how to spot risk earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of either bile duct cancer (CGC) or gallbladder cancer (GBC).
- OR, if you are a comparison participant: you must be cancer-free (healthy control) or have chronic liver disease (CLD) with no cancer history.
- If you are a healthy control, you should have no current or past cancer.
- If you have chronic liver disease, you must not have liver cancer on CT or MRI scans.
- The study needs participants matched by age (within 5 years), gender, and race, and the comparison partners are typically friends or spouses of certain other patients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study follows people with bile duct cancer or certain liver cancers to better understand their disease. You might be included if you meet the diagnosis and basic participation requirements.
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
This study is testing a new way to use a simple blood test to help diagnose cholangiocarcinoma (bile duct cancer) earlier and more accurately. It is for people whose tumors can be surgically removed and who have not had prior cancer treatment.
This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.